In the News
Keep up to date with the latest news articles from around the world.
Articles represent the views of their authors and not ME/CFS SA. Always seek advice from a registered health practitioner before changing your care plan.
13 February, 2024
Fibromyalgia, Sleep Disturbance Linked To Poor Accuracy For Divided Attention
A new study found patients with fibromyalgia had greater sleep disturbance and thus poorer accuracy for divided attention tasks than healthy controls.
13 February, 2024
Researchers Start To Find Clues On The Trail Of Long Covid
Tens of millions of people across the world are thought to suffer from long Covid, but four years after the pandemic was declared this elusive condition still cannot be tested for -- let alone treated. However research could be finally starting to find early clues on the trail of long Covid, raising hopes of future breakthroughs that may also illuminate other stubbornly ambiguous chronic syndromes.
12 February, 2024
Promising Phase 3 Trial Results of Innovative NonOpioid Painkiller for Fibromyalgia Patients
Tonix Pharmaceuticals has recently announced promising findings from a Phase 3 clinical trial conducted on TNX-102 SL, their innovative non-opioid painkiller specially developed to alleviate the symptoms of fibromyalgia. This breakthrough medication has demonstrated remarkable efficacy in reducing widespread pain, enhancing sleep quality, and mitigating fatigue among fibromyalgia patients. The trial successfully met its primary objective, paving the way for potential FDA approval in 2025. TNX-102 SL, a centrally acting analgesic, functions by improving sleep patterns, thereby providing relief from chronic pain associated with fibromyalgia.
12 February, 2024
AIM’s Ampligen Stumbles In Phase II Trial
AIM’s Ampligen failed to meet its primary endpoint in the Phase II trial in people with post-Covid fatigue.
11 February, 2024
Ivermectin Rendered Useless For COVID And Similar Viruses
Two people write in to Dr Keith Roach, MD, at US news outlet The Daily Independent Online, one about Ivermectin, and the other about ME/CFS.
11 February, 2024
Telltale Amino Acid Deficiencies May Hold The Key To New Treatments For Long COVID, Say Researchers
A University of Alberta research team brings together immunologists, virologists, rheumatologists and metabolomics experts in an effort to discover exactly what is ailing the sickest long COVID patients and find treatments for them. In research recently published in Frontiers in Immunology, the team reports that a disproportionate number of people affected—nearly 70%—are female and face debilitating symptoms that are identical to chronic fatigue syndrome, now referred to as myalgic encephalomyelitis/chronic fatigue syndrome or ME/CFS. Blood samples show tell-tale amino acid deficiencies, suggesting readily available supplements have potential as therapy.
11 February, 2024
Fifers Speak Out Over ME Care Crisis: ‘I Ended Up Having To Diagnose Myself’
Stella Larg is among those left angry and frustrated after the last ME specialist in Scotland passed away and was not replaced, with the service instead being 'paused'.
10 February, 2024
The Sickest Long COVID Patients Face Symptoms Identical To Chronic Fatigue Syndrome
Telltale amino acid deficiencies may hold the key to new treatments, say researchers.
10 February, 2024
I Have Chronic Fatigue Syndrome. These Are My Top Self-Care Tips To Have More Energy And Feel Less Exhausted.
Amy Arthur was diagnosed with chronic fatigue syndrome at 15. She's learned rest is essential to her self-care since then.
10 February, 2024
Effect of Steroids On Patients With Fibromyalgia/Chromic Widespread Pain: An Observational Study
A study has found that Fibromyalgia patients with thyroid autoimmunity responded well to short courses of steroids. Greater pain relief was observed among those who are strongly positive anti-TPO Ab group.
